Showing results (21-30 of 51) with videos related to
Sort By:
Pageof 6
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|January 24, 2026
Evaluation of Inflammatory Parameters and Ferritin as Prognostic Factors in Non-small Cell Lung Cancer Patients Receiving Nivolumab Immunotherapyİsmail Beypınar, Onur Yazdan Balçık, Semiha Urvay, et al.The Prostate|November 24, 2025
Prognostic Effect of KELIM Score of Prostate-Specific Antigen in Hormone-Sensitive Prostate Cancer Patients Treated With Novel Androgen Receptor Inhibitors: Pioneering New WaysYusuf Ilhan, Murat Araz, Ali Fuat Gurbuz, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|November 21, 2017
Efficacy and safety of cetuximab plus FOLFOX in second-line and third-line therapy in metastatic colorectal cancerErsin Ozaslan, Ulaş Serkan Topaloglu, Mevlude Inanc, et al.Archives of Gynecology and Obstetrics|March 24, 2023
Relationship between molecular markers and lymphadenectomy and lymphovascular space invasion in endometrial cancerFiliz Bilir, Dagıstan Tolga Arıoz, Suna Evrim Arıkan, et al.Medicina (Kaunas, Lithuania)|June 27, 2025
Illuminating Bilateral Breast Cancer: A Multicenter Experience and Clinical ObservationsBerkan Karabuğa, Mustafa Büyükkör, Ekin Konca Karabuğa, et al.Medicina (Kaunas, Lithuania)|May 27, 2026
Does the Duration of FLOT Infusion Change the Outcome of Perioperative Treatment for Gastric Cancer? Comparing 24- and 48-h InfusionsHacer Demir, Canan Yıldız, Yusuf İlhan, et al.Anti-Cancer Drugs|October 22, 2016
Comparison of survival with somatostatin analog and chemotherapy and prognostic factors for treatment in 165 advanced neuroendocrine tumor patients with Ki-67 20% or lessErsin Özaslan, Halit Karaca, Sinan Koca, et al.JCO Global Oncology|March 19, 2026
Prevalence and Reactivation of Hepatitis B and C in Patients Undergoing Chemotherapy for Solid TumorsMustafa Gürbüz, Deniz Tural, Timuçin Çil, et al.Journal of Chemotherapy (Florence, Italy)|June 21, 2024
Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter studyÖzgecan Dülgar, Sema Türker, Gül Başaran, et al.Balkan Medical Journal|January 24, 2020
Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter TrialAtakan Demir, Nil Molinas Mandel, Semra Paydas, et al.Pageof 6